SERION ELISA agile SARS-CoV-2 IgA, IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human antibodies in serum or plasma directed against SARS-CoV-2 and are recommended to support in the diagnosis of COVID-19 and as a complement to direct pathogen detection. In addition SERION ELISA agile SARS-CoV-2 IgG can be used for epidemiological studies.
Highlights
- The utilization of the whole spike protein ensures an early and sensitive detection of SARS-CoV-2 IgG
- Quantitative IgG test allows monitoring of immune response after infection or vaccination
- Expression of SARS-CoV-2 IgG antibody activity in standardized BAU/ml possible
- Detection of intrathecally synthesized IgG antibodies for CSF diagnostics
- Excellent correlation of the IgG test with neutralization assays
- Sensitive IgA and IgM antibody detection with high specificity ideal for determination of acute infections as complement to direct pathogen detection
- Quantitative eveluation of IgA antibody activities
- In house produced antigens guarantee relibale and reproducible results